Advisory Board

The CCC's Advisory Board was restructured in the fall of 2006 to create a smaller group of external stakeholders to advise the Centre. The new Advisory Board consists of members who provide a balance of high-level, strategic perspectives from across the Canadian healthcare landscape. Members come from various sectors and include clinician, research, policy and consumer representatives. These members have the capacity to strengthen the development of Cochrane activities, linkages and funding stability in Canada with their strategic advice and strong capacity for an advocacy role.

The previous Advisory Board members, consisting of a total of 47 Canadian group, partner and regional site representatives, still have a role of providing advice and support to the Centre by serving as a stakeholder group. They continue to provide input into strategic direction and implementation by participating in working groups and committees.

Advisory Board

NamePosition
Krista Connell (Chair)Chief Executive Officer; Nova Scotia Health Research Foundation
Halifax, Nova Scotia
Timothy CaulfieldCanadian Research Chair in Health Law and Policy
Professor, Faculty of Law and School of Public Health,
Health Law Institute, University of Alberta
Edmonton, Alberta 
Heather DavidsonAssistant Deputy Minister, B.C. Health Planning and Innovation Division, Ministry of Health
Victoria, British Columbia 
Jean LégaréPatient Partner in the Canadian Arthritis Network
Québec City, Québec
Stuart MacLeodSenior Clinician Scientist, Child and Family Research Institute (CFRI)
Professor, Division of Administration, Department of Pediatrics, University of British Columbia
Vice President, Academic Liaison and Research Coordinator, Provincial Health Services Authority
Vancouver, British Columbia
François RousseauProfesseur (médecin)
Unité de recherche en génétique humaine et moléculaire
Université Laval & CHUQ
Université Laval
Québec City, Québec
Vasanthi SrinivasanExecutive Director, Ontario SPOR SUPPORT Unit
Toronto, Ontario